Integrating New Data From AIDS 2022

Join 2 leading experts for an interactive Webinar focused on the most clinically relevant data presented at AIDS 2022, as well as other key studies that may be significant to the advancement of HIV patient care. Case vignettes will be used to explore integration of findings into everyday patient management.

These in-depth 90-minute CME/CE/CPE-certified Webinars are open to all members. The regional designations listed are to encourage a more localized, small-group format and to better allow that some questions or issues may be addressed by faculty from the specific region.

NOTE: Time zones vary by program region - please confirm the workshop time zone when you register.

 

September 27, 2022 – Midwest (MT, WY, CO, ND, SD, NE, KS, MN, IA, MO, WI, IL, MI)

October 5, 2022 – Mid-Atlantic (VA, WV, MD, DC, DE)

October 6, 2022 – Southeast US

October 11, 2022 – Southwest US (TX, AZ, NM, OK)

Agenda

The timing and agenda for each webinar is as follows:

  • Introduction and Program Overview
  • Key Findings From AIDS 2022
    • Clinical studies of established antiretroviral agents
    • The clinical role(s) of new and investigational ART regimens
    • HIV prevention strategies
  • Question and Answer Session

Events

Date / Time
Event Details

Faculty

Program Director
Milena Murray, PharmD

Associate Professor
Department of Pharmacy Practice
Midwestern University College of Pharmacy, Downers Grove Campus
Downers Grove, Illinois
System-Level HIV/ID Clinical Pharmacist
Ambulatory Pharmacy
Northwestern Medicine
Wheaton, Illinois

Faculty
Roger Bedimo, MD, MS, FACP

Professor of Medicine
Division of Infectious Diseases
University of Texas Southwestern Medical Center
Section Chief
Division of Infectious Diseases
Department of Internal Medicine
VA North Texas Health Care System
Dallas, Texas

Faculty
W David Hardy MD, MD

Scientific and Medical Consultant
Adjunct Clinical Professor of Medicine

Division of Infectious Diseases
Keck School of Medicine of USC
Los Angeles, California

Faculty
Gregory Huhn, MD, MPHTM

Professor of Medicine
Department of Infectious Diseases
Rush University Medical Center
Interim Chief
Division of Infectious Diseases
Cook County Health
Chicago, Illinois

Faculty
Princy N. Kumar, MD, FIDSA, MACP

Professor of Medicine and Microbiology
Chief, 
Division of Infectious Diseases and Travel Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC

Faculty
Jeffrey Kwong, DNP, MPH, AGPCNP-BC, FAANP, FAAN

Professor
Division of Advanced Nursing Practice
Rutgers School of Nursing
Newark, New Jersey
Nurse Practitioner
Gotham Medical Group
New York, New York

Faculty
Mary W. Montgomery, MD

Instructor of Medicine
Harvard Medical School
Associate Professor
Division of Infectious Disease
Department of Medicine
Brigham and Women's Hospital
Boston, Massachusetts

Faculty
William R. Short, MD, MPH, AAHIVS

Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

Faculty
Marc A. Tribble, MD

Clinical Assistant Professor
Division of Infectious Diseases
Baylor University Medical Center at Dallas
Dallas, Texas

Faculty
David A. Wohl, MD

Professor of Medicine
School of Medicine
Site Leader, Global Infectious Diseases
Clinical Trials Unit
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Goal Statement
The goal of this activity is to improve learners’ competence in implementing optimal HIV treatment and prevention strategies through the appropriate use of contemporary ARV regimens.

Target Audience
This program is intended for physicians, registered nurses, pharmacists, and other healthcare professionals who provide care for patients with HIV infection.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Integrate best practices in the evidence-based management of ART across the spectrum of ART experience
  • Incorporate the latest data and expert insights on emerging innovative ARV treatment or prevention paradigms into the individualized care of persons with or at risk of HIV infection
  • Appropriately counsel patients regarding the anticipated clinical role of new and investigational ART regimens

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Designation of Credit

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-22-173-L02-P

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.